| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.50B | +11.0% |
| Cost of Revenue | $277.5M | +7.7% |
| Gross Profit | $1.22B | +11.8% |
| R&D Expense | $307.6M | +9.4% |
| SG&A Expense | $217.3M | +3.3% |
| Operating Income | $362.6M | +20.0% |
| Interest Expense | $7.6M | -55.3% |
| Pre-tax Income | $350.7M | +19.7% |
| Income Tax | $73.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $123.3M | +92.6% |
| Current Assets | $539.0M | +21.9% |
| Total Assets | $3.56B | +4.6% |
| Current Liabilities | $960.2M | +17.9% |
| Long-term Debt | $1.25B | -10.0% |
| Total Liabilities | $2.37B | +0.3% |
| Stockholders' Equity | $1.19B | +14.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $538.5M | +23.7% |
| Capital Expenditures | $18.3M | +30.0% |
| Investing Cash Flow | -$112.3M | +21.6% |
| Financing Cash Flow | -$376.3M | -29.8% |
| Free Cash Flow | $520.2M | +23.5% |
| +24.3% |
| Net Income | $277.9M | +18.3% |
| EPS (Basic) | $0.88 | +17.3% |
| EPS (Diluted) | $0.85 | +18.1% |